In a study published in Cancer, the majority of patients who underwent allogeneic hematopoietic stem cell transplantation (alloHCT) and lived to 100 days did not report regretting their transplantation, and regret was instead found to be related to disease recurrence.
Given these findings, researchers suggested that social connectedness may serve as a protective factor against later regret. However, future work should explore regret in other patient groups and use qualitative methods to inform best practices for reducing regret.
“Considered a ‘high stakes’ medical treatment, the decision-making process and, relatedly, the informed consent process for HCT are complex,” the authors wrote. “Patients often are in a vulnerable state when asked to make decisions about treatment for a life-threatening illness that may have severe side effects.”
Researchers used Center for…